AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Capecitabine in South Africa
18 products registered with SAHPRA — 14 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CAPELODA 500 | 47/26/0364 | Cipla Medpro (Pty) Ltd | active | 11 Jan 2030 |
| CAPELODA 150 | 47/26/0363 | Cipla Medpro (Pty) Ltd | active | 11 Jan 2030 |
| CAPECITABINE CIPLA 150 | 47/26/0361 | Cipla Medpro (Pty) Ltd | suspended | 18 Mar 2025 |
| CAPECITABINE CIPLA 500 | 47/26/0362 | Cipla Medpro (Pty) Ltd | suspended | 18 Mar 2025 |
| CAPECITABINE 150 EUROLAB | 47/26/0807 | Eurolab (Pty) Ltd | suspended | 30 Jun 2023 |
| CAPECITABINE 500 EUROLAB | 47/26/0808 | Eurolab (Pty) Ltd | suspended | 30 Jun 2023 |
| XELODA 500 | 33/26/0199 | Equity Pharmaceutical (Pty) Ltd | active | 1 Jan 1900 |
| TANICEP 500 | 54/26/0265 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| CAPTERO 500 | 54/26/0267.265 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| TANICEP 150 | 55/26/0423 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| BINECAP 150 | 55/26/0424.423 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| CAPTERO 150 | 55/26/0425.423 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| BINECAP 500 | 54/26/0266.265 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| AUROXEDA 500 mg | 53/26/0101 | Aurogen South Africa (Pty) Ltd | active | 1 Jan 1900 |
| REBUTRIX 150 mg | 53/26/0102 | Aurogen South Africa (Pty) Ltd | active | 1 Jan 1900 |
| AUROXEDA 150 mg | 53/26/0100 | Aurogen South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ETOPOSIDE 100 mg/5 ml ADCO | 53/26/0103 | Adcock Ingram Critical Care (Pty) Ltd | active | 1 Jan 1900 |
| XELODA 150 | 33/26/0198 | Equity Pharmaceutical (Pty) Ltd | active | 1 Jan 1900 |
Capecitabine — SAHPRA Registration Details
SAHPRA (South Africa) has 18 registered products containing Capecitabine, of which 14 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Capecitabine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.